×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
Senology / Breast / Webinar
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
16177 views

Programme

18:00
Pourquoi les chirurgiens doivent favoriser les traitements néo-adjuvants ?
Pr Fabien Reyal
 
18:20
Prise en charge des patientes métastatiques synchrones
Pr Jean-Yves Pierga
18:40 Prise en charge des récidives régionales isolées
Dr Sarah Differding
 
19:00 Débat/discussion - Réponses aux questions

 
Réunion modérée par Pr Fabien Reyal

Shooting date : 2021-04-14
Last update : 2022-12-19
Jean-Yves Pierga
Paris, France
Private message
Sarah Differding
Paris, France
Private message
Fabien Reyal
Paris, France
Private message

Cancer breast

1 Videos / Public /

Share
Discover playlist

Sein

10 Videos / Public /

Share
Discover playlist

Videos a voir

9 Videos / Public /

Share
Discover playlist
2 comments
Join the Discussion
  • Delphine M.

    Delphine M. Oui je suis là!!!

    2021-04-14, 19h31
      Join files
      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Kheloudja B.

      Kheloudja B. les tumeurs de 2 cm ou plus HER2 surexprimé , reçoivent une chimiothérapie néoadjuavnte et si pas de yp0yPn0 , du TDM 1 en adjuvant . que disent les données sur les tumemeurs HER2+ qui ne reçoivent de néoadj car petites de taille qui au final recevront herception en adjuvant mais ne connaissant pas leur sensibilité au néoadj , est ce que celles qui n'auraient pas répondu ne rateraient pas le bénéfice du TDM1 en adjuvant , pourquoi pas du néoadj pour toutes lees HER2+?

      2021-05-16, 23h12
        Join files
        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
      Honolulu : Thursday, October 13th 2022 from 07am to 08am (GMT+2)
      San Francisco : Thursday, October 13th 2022 from 10am to 11am (GMT+2)
      New York : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
      Buenos Aires : Thursday, October 13th 2022 from 02pm to 03pm (GMT+2)
      Reykjavik : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
      London / Dublin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
      Paris / Berlin : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
      Istanbul : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
      Moscou / Dubaï : Thursday, October 13th 2022 from 09pm to 10pm (GMT+2)
      Bangkok : Friday, October 14th 2022 from 12am to 01am (GMT+2)
      Shanghai : Friday, October 14th 2022 from 01am to 02am (GMT+2)
      Tokyo : Friday, October 14th 2022 from 02am to 03am (GMT+2)
      Sydney : Friday, October 14th 2022 from 04am to 05am (GMT+2)
      Wellington : Friday, October 14th 2022 from 06am to 07am (GMT+2)

      Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

      Les nouveaux traitements, entre choix et complémentarité

      Senology / Breast / Webinar
      View more
      Share
      Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
      Honolulu : Tuesday, May 14th 2024 from 07am to 08:30am (GMT+2)
      San Francisco : Tuesday, May 14th 2024 from 10am to 11:30am (GMT+2)
      New York : Tuesday, May 14th 2024 from 01pm to 02:30pm (GMT+2)
      Buenos Aires : Tuesday, May 14th 2024 from 02pm to 03:30pm (GMT+2)
      Reykjavik : Tuesday, May 14th 2024 from 05pm to 06:30pm (GMT+2)
      London / Dublin : Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
      Paris / Berlin : Tuesday, May 14th 2024 from 07pm to 08:30pm (GMT+2)
      Istanbul : Tuesday, May 14th 2024 from 08pm to 09:30pm (GMT+2)
      Moscou / Dubaï : Tuesday, May 14th 2024 from 09pm to 10:30pm (GMT+2)
      Bangkok : Wednesday, May 15th 2024 from 12am to 01:30am (GMT+2)
      Shanghai : Wednesday, May 15th 2024 from 01am to 02:30am (GMT+2)
      Tokyo : Wednesday, May 15th 2024 from 02am to 03:30am (GMT+2)
      Sydney : Wednesday, May 15th 2024 from 04am to 05:30am (GMT+2)
      Wellington : Wednesday, May 15th 2024 from 06am to 07:30am (GMT+2)

      Développement thérapeutique dans les cancers du sein triples négatifs métastatiques

      Les webinars du réseau FEM-NET

      Senology / Breast / Webinar
      View more
      Share
      Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Wednesday, March 13th 2024 from 07am to 08:30am (GMT+1)
      San Francisco : Wednesday, March 13th 2024 from 09am to 10:30am (GMT+1)
      New York : Wednesday, March 13th 2024 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Wednesday, March 13th 2024 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Wednesday, March 13th 2024 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
      Istanbul : Wednesday, March 13th 2024 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Wednesday, March 13th 2024 from 09pm to 10:30pm (GMT+1)
      Bangkok : Thursday, March 14th 2024 from 12am to 01:30am (GMT+1)
      Shanghai : Thursday, March 14th 2024 from 01am to 02:30am (GMT+1)
      Tokyo : Thursday, March 14th 2024 from 02am to 03:30am (GMT+1)
      Sydney : Thursday, March 14th 2024 from 03am to 04:30am (GMT+1)
      Wellington : Thursday, March 14th 2024 from 05am to 06:30am (GMT+1)

      Prise en charge du cancer HER2+ métastatique

      Cycle d'enseignement - Le cancer du sein

      Senology / Breast / Webinar
      View more
      Share
      Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Thursday, January 18th 2024 from 07am to 08:30am (GMT+1)
      San Francisco : Thursday, January 18th 2024 from 09am to 10:30am (GMT+1)
      New York : Thursday, January 18th 2024 from 12pm to 01:30pm (GMT+1)
      Buenos Aires : Thursday, January 18th 2024 from 02pm to 03:30pm (GMT+1)
      London / Dublin : Thursday, January 18th 2024 from 05pm to 06:30pm (GMT+1)
      Paris / Berlin : Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+1)
      Istanbul : Thursday, January 18th 2024 from 07pm to 08:30pm (GMT+1)
      Moscou / Dubaï : Thursday, January 18th 2024 from 09pm to 10:30pm (GMT+1)
      Bangkok : Friday, January 19th 2024 from 12am to 01:30am (GMT+1)
      Shanghai : Friday, January 19th 2024 from 01am to 02:30am (GMT+1)
      Tokyo : Friday, January 19th 2024 from 02am to 03:30am (GMT+1)
      Sydney : Friday, January 19th 2024 from 03am to 04:30am (GMT+1)
      Wellington : Friday, January 19th 2024 from 05am to 06:30am (GMT+1)

      Cancer du sein triple négatif métastatique

      Cycle d'enseignement - Le cancer du sein

      Senology / Breast / Webinar
      View more
      Share
      Scroll Up